Feasibility analysis report (revised) for the use of funds raised from the issuance of A shares of Remegen in 2024 to specific objects.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.